APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastrointestinal Stromal Tumor (GIST) Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastrointestinal Stromal Tumor (GIST) Drug Industry Growth and Trends Forecast to 2032

22 December 2025115 pages

Choose your research edition.

Industry ResearchGastrointestinal Stromal Tumor (GIST) Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastrointestinal Stromal Tumor (GIST) Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Gastrointestinal Stromal Tumor (GIST) Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastrointestinal Stromal Tumor (GIST) Drug Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Gastrointestinal Stromal Tumor (GIST) Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastrointestinal Stromal Tumor (GIST) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastrointestinal Stromal Tumor (GIST) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastrointestinal Stromal Tumor (GIST) Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug include Novartis AG, Jiangsu Hengrui Medicine Co., Ltd., Omeros Corporation, Nerviano Medical Sciences S.r.l., Natco Pharma Limited, Kolltan Pharmaceuticals, Inc., Immunicum AB, Horizon Pharma Plc and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastrointestinal Stromal Tumor (GIST) Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastrointestinal Stromal Tumor (GIST) Drug market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastrointestinal Stromal Tumor (GIST) Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastrointestinal Stromal Tumor (GIST) Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gastrointestinal Stromal Tumor (GIST) Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastrointestinal Stromal Tumor (GIST) Drug Market by Company

Novartis AG

Jiangsu Hengrui Medicine Co., Ltd.

Omeros Corporation

Nerviano Medical Sciences S.r.l.

Natco Pharma Limited

Kolltan Pharmaceuticals, Inc.

Immunicum AB

Horizon Pharma Plc

F. Hoffmann-La Roche Ltd.

Deciphera Pharmaceuticals, LLC

Chipscreen Biosciences Ltd

Calithera Biosciences, Inc.

Boston Biomedical, Inc.

Blueprint Medicines Corporation

Astex Pharmaceuticals, Inc.

Array BioPharma Inc.

Arog Pharmaceuticals, Inc.

Ariad Pharmaceuticals, Inc.

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type

Amcasertib

Anagrelide hydrochloride CR

APG-1351

Binimetinib

Others

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application

Clinic

Hospital

Others

Gastrointestinal Stromal Tumor (GIST) Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastrointestinal Stromal Tumor (GIST) Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastrointestinal Stromal Tumor (GIST) Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastrointestinal Stromal Tumor (GIST) Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gastrointestinal Stromal Tumor (GIST) Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gastrointestinal Stromal Tumor (GIST) Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Amcasertib Table 2. Major Company of Anagrelide hydrochloride CR Table 3. Major Company of APG-1351 Table 4. Major Company of Binimetinib Table 5. Major Company of Others Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2026) & (US$/unit) Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (k units) Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2027-2032) & (US$/unit) Table 17. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 18. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 20. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 24. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends Table 28. Gastrointestinal Stromal Tumor (GIST) Drug Industry Drivers Table 29. Gastrointestinal Stromal Tumor (GIST) Drug Industry Opportunities and Challenges Table 30. Gastrointestinal Stromal Tumor (GIST) Drug Industry Restraints Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2021-2026) Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2021-2026) & (k units) Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Company (2021-2026) Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Major Company Production Sites and Headquarters Table 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Company, Product Type & Application Table 39. Global Gastrointestinal Stromal Tumor (GIST) Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021-2026) & (k units) Table 44. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2027-2032) & (k units) Table 49. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 55. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2026) & (US$/unit) Table 59. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (k units) Table 60. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2027-2032) & (US$/unit) Table 64. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 65. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 67. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 71. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Novartis AG Company Information Table 75. Novartis AG Business Overview Table 76. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 78. Novartis AG Recent Development Table 79. Jiangsu Hengrui Medicine Co., Ltd. Company Information Table 80. Jiangsu Hengrui Medicine Co., Ltd. Business Overview Table 81. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 83. Jiangsu Hengrui Medicine Co., Ltd. Recent Development Table 84. Omeros Corporation Company Information Table 85. Omeros Corporation Business Overview Table 86. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 88. Omeros Corporation Recent Development Table 89. Nerviano Medical Sciences S.r.l. Company Information Table 90. Nerviano Medical Sciences S.r.l. Business Overview Table 91. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 93. Nerviano Medical Sciences S.r.l. Recent Development Table 94. Natco Pharma Limited Company Information Table 95. Natco Pharma Limited Business Overview Table 96. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 98. Natco Pharma Limited Recent Development Table 99. Kolltan Pharmaceuticals, Inc. Company Information Table 100. Kolltan Pharmaceuticals, Inc. Business Overview Table 101. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 103. Kolltan Pharmaceuticals, Inc. Recent Development Table 104. Immunicum AB Company Information Table 105. Immunicum AB Business Overview Table 106. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 108. Immunicum AB Recent Development Table 109. Horizon Pharma Plc Company Information Table 110. Horizon Pharma Plc Business Overview Table 111. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 113. Horizon Pharma Plc Recent Development Table 114. F. Hoffmann-La Roche Ltd. Company Information Table 115. F. Hoffmann-La Roche Ltd. Business Overview Table 116. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 118. F. Hoffmann-La Roche Ltd. Recent Development Table 119. Deciphera Pharmaceuticals, LLC Company Information Table 120. Deciphera Pharmaceuticals, LLC Business Overview Table 121. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 123. Deciphera Pharmaceuticals, LLC Recent Development Table 124. Chipscreen Biosciences Ltd Company Information Table 125. Chipscreen Biosciences Ltd Business Overview Table 126. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 128. Chipscreen Biosciences Ltd Recent Development Table 129. Calithera Biosciences, Inc. Company Information Table 130. Calithera Biosciences, Inc. Business Overview Table 131. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 133. Calithera Biosciences, Inc. Recent Development Table 134. Boston Biomedical, Inc. Company Information Table 135. Boston Biomedical, Inc. Business Overview Table 136. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 138. Boston Biomedical, Inc. Recent Development Table 139. Blueprint Medicines Corporation Company Information Table 140. Blueprint Medicines Corporation Business Overview Table 141. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 143. Blueprint Medicines Corporation Recent Development Table 144. Astex Pharmaceuticals, Inc. Company Information Table 145. Astex Pharmaceuticals, Inc. Business Overview Table 146. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 148. Astex Pharmaceuticals, Inc. Recent Development Table 149. Array BioPharma Inc. Company Information Table 150. Array BioPharma Inc. Business Overview Table 151. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 153. Array BioPharma Inc. Recent Development Table 154. Arog Pharmaceuticals, Inc. Company Information Table 155. Arog Pharmaceuticals, Inc. Business Overview Table 156. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 158. Arog Pharmaceuticals, Inc. Recent Development Table 159. Ariad Pharmaceuticals, Inc. Company Information Table 160. Ariad Pharmaceuticals, Inc. Business Overview Table 161. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio Table 163. Ariad Pharmaceuticals, Inc. Recent Development Table 164. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 166. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2021-2026) Table 167. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032) & (k units) Table 168. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Country (2027-2032) Table 169. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026) & (US$ Million) Table 171. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country (2021-2026) Table 172. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Country (2027-2032) Table 174. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 175. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 176. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2021-2026) Table 177. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032) & (k units) Table 178. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Country (2027-2032) Table 179. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026) & (US$ Million) Table 181. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country (2021-2026) Table 182. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Country (2027-2032) Table 184. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 185. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 186. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2021-2026) Table 187. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032) & (k units) Table 188. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026) & (US$ Million) Table 191. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country (2021-2026) Table 192. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Country (2027-2032) Table 194. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 195. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 196. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2021-2026) Table 197. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032) & (k units) Table 198. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Country (2027-2032) Table 199. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026) & (US$ Million) Table 201. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country (2021-2026) Table 202. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Country (2027-2032) Table 204. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 205. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (k units) Table 206. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2021-2026) Table 207. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032) & (k units) Table 208. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026) & (US$ Million) Table 211. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country (2021-2026) Table 212. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Country (2027-2032) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List Table 217. Gastrointestinal Stromal Tumor (GIST) Drug Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Image Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (2021-2032) & (k units) Figure 5. Amcasertib Image Figure 6. Global Amcasertib Sales YoY Growth (2021-2032) & (k units) Figure 7. Anagrelide hydrochloride CR Image Figure 8. Global Anagrelide hydrochloride CR Sales YoY Growth (2021-2032) & (k units) Figure 9. APG-1351 Image Figure 10. Global APG-1351 Sales YoY Growth (2021-2032) & (k units) Figure 11. Binimetinib Image Figure 12. Global Binimetinib Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type 2025 VS 2032 Figure 17. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application 2025 VS 2032 Figure 37. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Gastrointestinal Stromal Tumor (GIST) Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Amcasertib
  • Anagrelide hydrochloride CR
  • APG-1351
  • Binimetinib
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Novartis AG
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Omeros Corporation
  • Nerviano Medical Sciences S.r.l.
  • Natco Pharma Limited
  • Kolltan Pharmaceuticals, Inc.
  • Immunicum AB
  • Horizon Pharma Plc
  • F. Hoffmann-La Roche Ltd.
  • Deciphera Pharmaceuticals, LLC
  • Chipscreen Biosciences Ltd
  • Calithera Biosciences, Inc.
  • Boston Biomedical, Inc.
  • Blueprint Medicines Corporation
  • Astex Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Arog Pharmaceuticals, Inc.
  • Ariad Pharmaceuticals, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gastrointestinal Stromal Tumor (GIST) Drug Market by Type
  6. 1.3.1 Amcasertib
  7. 1.3.2 Anagrelide hydrochloride CR
  8. 1.3.3 APG-1351
  9. 1.3.4 Binimetinib
  10. 1.3.5 Others
  11. 1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
  12. 1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
  2. 2.2 Gastrointestinal Stromal Tumor (GIST) Drug Industry Drivers
  3. 2.3 Gastrointestinal Stromal Tumor (GIST) Drug Industry Opportunities and Challenges
  4. 2.4 Gastrointestinal Stromal Tumor (GIST) Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Gastrointestinal Stromal Tumor (GIST) Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Gastrointestinal Stromal Tumor (GIST) Drug Price (2021-2026)
  4. 3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Gastrointestinal Stromal Tumor (GIST) Drug Company, Product Type & Application
  7. 3.7 Global Gastrointestinal Stromal Tumor (GIST) Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gastrointestinal Stromal Tumor (GIST) Drug Tier 1, Tier 2, and Tier 3
4 Gastrointestinal Stromal Tumor (GIST) Drug Regional Status and Outlook
  1. 4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size by Region
  3. 4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Region
  7. 4.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gastrointestinal Stromal Tumor (GIST) Drug by Application
  1. 5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
  6. 5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Jiangsu Hengrui Medicine Co., Ltd.
  8. 6.2.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information
  9. 6.2.2 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
  10. 6.2.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  12. 6.2.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
  13. 6.3 Omeros Corporation
  14. 6.3.1 Omeros Corporation Company Information
  15. 6.3.2 Omeros Corporation Business Overview
  16. 6.3.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  18. 6.3.5 Omeros Corporation Recent Developments
  19. 6.4 Nerviano Medical Sciences S.r.l.
  20. 6.4.1 Nerviano Medical Sciences S.r.l. Company Information
  21. 6.4.2 Nerviano Medical Sciences S.r.l. Business Overview
  22. 6.4.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  24. 6.4.5 Nerviano Medical Sciences S.r.l. Recent Developments
  25. 6.5 Natco Pharma Limited
  26. 6.5.1 Natco Pharma Limited Company Information
  27. 6.5.2 Natco Pharma Limited Business Overview
  28. 6.5.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  30. 6.5.5 Natco Pharma Limited Recent Developments
  31. 6.6 Kolltan Pharmaceuticals, Inc.
  32. 6.6.1 Kolltan Pharmaceuticals, Inc. Company Information
  33. 6.6.2 Kolltan Pharmaceuticals, Inc. Business Overview
  34. 6.6.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  36. 6.6.5 Kolltan Pharmaceuticals, Inc. Recent Developments
  37. 6.7 Immunicum AB
  38. 6.7.1 Immunicum AB Company Information
  39. 6.7.2 Immunicum AB Business Overview
  40. 6.7.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  42. 6.7.5 Immunicum AB Recent Developments
  43. 6.8 Horizon Pharma Plc
  44. 6.8.1 Horizon Pharma Plc Company Information
  45. 6.8.2 Horizon Pharma Plc Business Overview
  46. 6.8.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  48. 6.8.5 Horizon Pharma Plc Recent Developments
  49. 6.9 F. Hoffmann-La Roche Ltd.
  50. 6.9.1 F. Hoffmann-La Roche Ltd. Company Information
  51. 6.9.2 F. Hoffmann-La Roche Ltd. Business Overview
  52. 6.9.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  54. 6.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
  55. 6.10 Deciphera Pharmaceuticals, LLC
  56. 6.10.1 Deciphera Pharmaceuticals, LLC Company Information
  57. 6.10.2 Deciphera Pharmaceuticals, LLC Business Overview
  58. 6.10.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  60. 6.10.5 Deciphera Pharmaceuticals, LLC Recent Developments
  61. 6.11 Chipscreen Biosciences Ltd
  62. 6.11.1 Chipscreen Biosciences Ltd Company Information
  63. 6.11.2 Chipscreen Biosciences Ltd Business Overview
  64. 6.11.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  66. 6.11.5 Chipscreen Biosciences Ltd Recent Developments
  67. 6.12 Calithera Biosciences, Inc.
  68. 6.12.1 Calithera Biosciences, Inc. Company Information
  69. 6.12.2 Calithera Biosciences, Inc. Business Overview
  70. 6.12.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  72. 6.12.5 Calithera Biosciences, Inc. Recent Developments
  73. 6.13 Boston Biomedical, Inc.
  74. 6.13.1 Boston Biomedical, Inc. Company Information
  75. 6.13.2 Boston Biomedical, Inc. Business Overview
  76. 6.13.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  78. 6.13.5 Boston Biomedical, Inc. Recent Developments
  79. 6.14 Blueprint Medicines Corporation
  80. 6.14.1 Blueprint Medicines Corporation Company Information
  81. 6.14.2 Blueprint Medicines Corporation Business Overview
  82. 6.14.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  84. 6.14.5 Blueprint Medicines Corporation Recent Developments
  85. 6.15 Astex Pharmaceuticals, Inc.
  86. 6.15.1 Astex Pharmaceuticals, Inc. Company Information
  87. 6.15.2 Astex Pharmaceuticals, Inc. Business Overview
  88. 6.15.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  90. 6.15.5 Astex Pharmaceuticals, Inc. Recent Developments
  91. 6.16 Array BioPharma Inc.
  92. 6.16.1 Array BioPharma Inc. Company Information
  93. 6.16.2 Array BioPharma Inc. Business Overview
  94. 6.16.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  96. 6.16.5 Array BioPharma Inc. Recent Developments
  97. 6.17 Arog Pharmaceuticals, Inc.
  98. 6.17.1 Arog Pharmaceuticals, Inc. Company Information
  99. 6.17.2 Arog Pharmaceuticals, Inc. Business Overview
  100. 6.17.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  102. 6.17.5 Arog Pharmaceuticals, Inc. Recent Developments
  103. 6.18 Ariad Pharmaceuticals, Inc.
  104. 6.18.1 Ariad Pharmaceuticals, Inc. Company Information
  105. 6.18.2 Ariad Pharmaceuticals, Inc. Business Overview
  106. 6.18.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Portfolio
  108. 6.18.5 Ariad Pharmaceuticals, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
  2. 7.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  6. 7.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
  2. 8.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  6. 8.2.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
  2. 9.1.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
  2. 10.1.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  6. 10.2.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
  2. 11.1.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gastrointestinal Stromal Tumor (GIST) Drug Value Chain Analysis
  2. 12.1.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process
  7. 12.2 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
  10. 12.2.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst